These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 14655446)
21. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. Ballard CG; Margallo-Lana ML J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968 [TBL] [Abstract][Full Text] [Related]
22. Role of risperidone in children with autism spectrum disorder. Chavez B; Chavez-Brown M; Rey JA Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811 [TBL] [Abstract][Full Text] [Related]
23. Reader response to, "Effects of risperidone on aberrant behavior in persons with developmental disabilities: I. A double-blind crossover study using multiple measures". Levitas A Am J Ment Retard; 2003 May; 108(3):212-4; author reply 214-6. PubMed ID: 12691600 [No Abstract] [Full Text] [Related]
25. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
26. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia. Dursun S J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780 [No Abstract] [Full Text] [Related]
27. Impractical features of long-acting risperidone. Amdur MA Psychiatr Serv; 2004 Dec; 55(12):1443; author reply 1443-4. PubMed ID: 15572577 [No Abstract] [Full Text] [Related]
28. The use of antipsychotic agents in the management of behavioral disorders in the elderly with dementia: evaluating recent clinical data. Worz CR Director; 2008; 16(2):17-20. PubMed ID: 19343879 [No Abstract] [Full Text] [Related]
30. Cerebrovascular events after treatment of dementia patients with risperidone. Wancata J Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366 [No Abstract] [Full Text] [Related]
31. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [TBL] [Abstract][Full Text] [Related]
32. The use of risperidone among individuals with mental retardation: clinically supported or not? Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072 [TBL] [Abstract][Full Text] [Related]
34. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage]. Stoppe G; Schreiner A; Schmitt AB Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564 [TBL] [Abstract][Full Text] [Related]
35. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour. Shah A; Suh GH Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589 [No Abstract] [Full Text] [Related]
36. Mortality in elderly dementia patients treated with risperidone. Haupt M; Cruz-Jentoft A; Jeste D J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812 [TBL] [Abstract][Full Text] [Related]
37. [Facilitating nursing at home and in the nursing home]. Krankenpfl J; 2005; 43(1-3):34-5. PubMed ID: 15912827 [No Abstract] [Full Text] [Related]
38. Risperidone and late onset tics. Feroz-Nainar C; Roy M Autism; 2006 May; 10(3):302-7. PubMed ID: 16682400 [No Abstract] [Full Text] [Related]
39. Bradycardia at low doses of risperidone. Tran KT; Golden P; Lark T; Jacob NJ Am J Psychiatry; 2004 Dec; 161(12):2325-6. PubMed ID: 15569911 [No Abstract] [Full Text] [Related]
40. Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia. Ezewuzie N; Taylor D J Psychopharmacol; 2006 Jan; 20(1):86-90. PubMed ID: 16174679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]